Zoetis Inc. (BMV:ZTS)
Mexico flag Mexico · Delayed Price · Currency is MXN
3,185.00
+55.71 (1.78%)
At close: May 12, 2025, 2:00 PM CST
11.87%
Market Cap 1.42T
Revenue (ttm) 189.80B
Net Income (ttm) 51.47B
Shares Out n/a
EPS (ttm) 113.85
PE Ratio 27.51
Forward PE 25.65
Dividend 36.51 (1.17%)
Ex-Dividend Date Apr 21, 2025
Volume 344
Average Volume 1,606
Open 3,185.00
Previous Close 3,129.29
Day's Range 3,185.00 - 3,185.00
52-Week Range 2,835.00 - 3,858.69
Beta n/a
RSI 58.63
Earnings Date May 6, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 13,800
Stock Exchange Mexican Stock Exchange
Ticker Symbol ZTS
Full Company Profile

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD Financial Statements

News

There is no news available yet.